Biomodel in Tetralogy of Fallot
Application of Biocardiac Model in Total Correction of Tetralogy of Fallot
1 other identifier
interventional
50
1 country
1
Brief Summary
Using biocardiac model in helping the total correction of the Tetralogy of Fallot.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started May 2005
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2005
CompletedFirst Submitted
Initial submission to the registry
September 8, 2005
CompletedFirst Posted
Study publicly available on registry
September 12, 2005
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2008
CompletedDecember 20, 2005
May 1, 2005
September 8, 2005
December 19, 2005
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
diagnostic accuracy
Secondary Outcomes (2)
sensitivity
specificity
Interventions
Eligibility Criteria
You may qualify if:
- Tetralogy of Fallot
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Dept. Medical Imaging, NTUH
Taipei, 100, Taiwan
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Shyh-Jye Chen, MD, PhD
Dept. Medical Imaging, NTUH
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
September 8, 2005
First Posted
September 12, 2005
Study Start
May 1, 2005
Study Completion
December 1, 2008
Last Updated
December 20, 2005
Record last verified: 2005-05